Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type - PubMed (original) (raw)
Comparative Study
. 2005 Sep;162(9):1738-40.
doi: 10.1176/appi.ajp.162.9.1738.
Affiliations
- PMID: 16135636
- DOI: 10.1176/appi.ajp.162.9.1738
Comparative Study
Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type
Guy Neeman et al. Am J Psychiatry. 2005 Sep.
Abstract
Objective: Altered glycine and homocysteine levels may contribute to N-methyl-D-aspartate receptor dysfunction in schizophrenia. The authors measured plasma levels of these amino acids in a group of patients with chronic schizophrenia and related them to the patients' symptom profiles and types of antipsychotic medication.
Method: Plasma levels of amino acids in 94 patients with schizophrenia were compared with those in 34 age- and sex-matched normal subjects. The Positive and Negative Syndrome Scale was used to evaluate the patients' psychopathology.
Results: Plasma glycine levels and glycine-serine ratios were lower and homocysteine levels were higher in patients than in comparison subjects. Low glycine levels correlated with a greater number of negative symptoms. The glycine-serine ratios of normal subjects and patients being treated with clozapine did not differ significantly.
Conclusions: These findings support the hypothesis that altered levels of glycine and homocysteine may coexist in patients with schizophrenia and contribute to pathophysiological aspects of this illness.
Similar articles
- Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.
Sumiyoshi T, Jin D, Jayathilake K, Lee M, Meltzer HY. Sumiyoshi T, et al. Int J Neuropsychopharmacol. 2005 Sep;8(3):451-5. doi: 10.1017/S1461145705005237. Epub 2005 Apr 7. Int J Neuropsychopharmacol. 2005. PMID: 15817136 Clinical Trial. - Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
Hons J, Vasatova M, Cermakova E, Doubek P, Libiger J. Hons J, et al. J Psychiatr Res. 2012 Jun;46(6):811-8. doi: 10.1016/j.jpsychires.2012.03.015. Epub 2012 Apr 13. J Psychiatr Res. 2012. PMID: 22502820 - Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
Sumiyoshi T, Anil AE, Jin D, Jayathilake K, Lee M, Meltzer HY. Sumiyoshi T, et al. Int J Neuropsychopharmacol. 2004 Mar;7(1):1-8. doi: 10.1017/S1461145703003900. Epub 2004 Jan 13. Int J Neuropsychopharmacol. 2004. PMID: 14720317 Clinical Trial. - Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.
Shim SS, Hammonds MD, Kee BS. Shim SS, et al. Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):16-27. doi: 10.1007/s00406-007-0757-8. Epub 2007 Sep 27. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 17901997 Review. - Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis.
Tsai GE, Lin PY. Tsai GE, et al. Curr Pharm Des. 2010;16(5):522-37. doi: 10.2174/138161210790361452. Curr Pharm Des. 2010. PMID: 19909229 Review.
Cited by
- The glycine deportation system and its pharmacological consequences.
Beyoğlu D, Idle JR. Beyoğlu D, et al. Pharmacol Ther. 2012 Aug;135(2):151-67. doi: 10.1016/j.pharmthera.2012.05.003. Epub 2012 May 11. Pharmacol Ther. 2012. PMID: 22584143 Free PMC article. Review. - Homocysteine levels in patients with schizophrenia on clozapine monotherapy.
Wysokiński A, Kłoszewska I. Wysokiński A, et al. Neurochem Res. 2013 Oct;38(10):2056-62. doi: 10.1007/s11064-013-1113-1. Epub 2013 Jul 20. Neurochem Res. 2013. PMID: 23873378 Free PMC article. - Neurophysiological biomarkers for drug development in schizophrenia.
Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M. Javitt DC, et al. Nat Rev Drug Discov. 2008 Jan;7(1):68-83. doi: 10.1038/nrd2463. Nat Rev Drug Discov. 2008. PMID: 18064038 Free PMC article. Review. - Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia.
Takano Y, Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Shinozaki T, Aoki A, Akiyama K, Homma H, Shimoda K. Takano Y, et al. Ann Gen Psychiatry. 2016 Aug 31;15(1):23. doi: 10.1186/s12991-016-0113-3. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27588034 Free PMC article. - Flaxseed Increases Animal Lifespan and Reduces Ovarian Cancer Severity by Toxically Augmenting One-Carbon Metabolism.
Weston WC, Hales KH, Hales DB. Weston WC, et al. Molecules. 2021 Sep 18;26(18):5674. doi: 10.3390/molecules26185674. Molecules. 2021. PMID: 34577143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical